2nd Clinical Trials Innovations Webinar - 21st March, 150 EUR
Agenda
- 12:00 UTC Login
- 12:05 UTC Webinar Opening
- 12:10 UTC Enabling Decentralized Trials in Asia – Rainbow Poon – Head of Global Development Operations, China & Operational Excellence Lead for Clinical Site Lead, Merck
- 12:50 UTC Clinical Trials in Rare Diseases – How Can Decentralization Help Optimize Rare Disease Trials? – Esther Mahillo – Vice President, Operational Strategy and Feasibility, Precision For Medicine
- 13:30 UTC The Significance of Diversity in Clinical Trials and How Writers Can Address It – Nomita Saxena Senior Director, Clinical Regulatory Writing, AstraZeneca
- 14:10 UTC A Different Outlook to Increase Patient Retention in Clinical Trials – Jennifer Lee – Former, Senior Vice President, Clinical Operations, Biostats, and Data Management, Elevar Therapeutics
- 14:50 UTC Coffee Break
- 15:20 UTC Data Exploration in Global Feasibility – Stephanie Vakaljan – Associate Director Feasibility and Recruitment Planning, GSK
- 16:00 UTC Translational Science Principles to Drive Clinical Trial Capability and Efficiency – Jennifer Barnes – Senior Director, Clinical Sciences, Aristea Therapeutics
- 16:40 UTC Patient Centricity Panel Discussion
- Moderator: Jennifer Lee, Former Senior Vice President,
- Clinical Operations, Biostats and Data Management, Elevar Therapeutic
- Panelists:
- Sarah Small, Associate Director, Patient Centricity, Moderna
- Isabela Niculae, Head Global Clinical Sciences & Operations
- Innovation, UCB
- Stephanie Vakaljan, Associate Director Feasibility
- and Recruitment Planning, GSK
- 17:20 UTC Closing Remarks
